Genocea Biosciences

Genocea Biosciences

Harnessing the power of T cells.

Human health & social work | Global | Access to Information |

 Profile Provided By: Company Website

Overview

Genocea finds targets of T cell responses to discover and develop life changing medicines.We ve created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases.Genocea's pipeline of novel T cell vaccines includes GEN 003 for HSV 2 therapy and GEN 004 a protein vaccine directed at pneumococcus both currently in Phase II clinical trials.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Operating 51 - 200 employees

Funding and Financing Rounds


Team


Impact

Geographies:

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

100 Acorn Park Drive Floor 5
Cambridge, Massachusetts 02140
United States of America



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


News & Links

Incoming

Twitter

Tweet from Genocea Biosciences: Did you miss #SITC2017? You can still see $GNCA's SITC posters on our website at https://t.co/muuD7SyuQP. #targetsmatter Posted Sun Nov 12 10:56 am

Tweet from Genocea Biosciences: $GNCA is well represented at #SITC2017! #targetsmatter https://t.co/KUowdtN2N7 Posted Fri Nov 10 10:14 am

Tweet from Genocea Biosciences: $GNCA will present at the Stifel 2017 Healthcare Conference on Wednesday, 11/15 at 8:45 a.m. in NYC. A live webcas… https://t.co/wr5KuMbLx5 Posted Wed Nov 8 5:38 am

Tweet from Genocea Biosciences: ATLAS identifies unique TAA response signatures in patients with lung and colorectal cancers. New data at #SITC2017. #targetsmatter Posted Tue Nov 7 10:34 am

Tweet from Genocea Biosciences: ATLAS demonstrates superiority to in silico methods of neoantigen identification in multiple tumor types. New data@#SITC2017. #targetsmatter Posted Tue Nov 7 7:01 am

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.